Ballast Inc’s Gilead Sciences GILD Stock Holding History

Ballast Inc’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,751	Closed	-$212K	–	89
2018 Q3	$212K	Buy	+2,751	New	+$208K	0.15%	91
2018 Q2	–	Sell	-2,751	Closed	-$207K	–	88
2018 Q1	$207K	Buy	+2,751	New	+$219K	0.17%	82

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ballast Inc's GILD Position: Q4 2018 in Review

Ballast Inc sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 2,751 shares — an estimated $212K sold.

Ballast Inc first reported a position in GILD in Q1 2018 and held it in 2 quarters. The position peaked at $212K in Q3 2018. 1,498 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

Ballast Inc reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
Ballast Inc sold 2,751 Gilead Sciences shares in Q4 2018, an estimated $212K.
Ballast Inc first reported a position in Gilead Sciences in Q1 2018 and held it in 2 quarters.
Ballast Inc's Gilead Sciences position peaked at $212K in Q3 2018.
1,498 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Ballast Inc's 13F filing for Q4 2018, filed 1 Feb 2019.